Introduction
Methods
Patients
Surgical procedures and perioperative administration
Culture of gastric juice and diagnosis of gastric Candida colonization
Evaluations of risk factors for gastric Candida colonization
Definitions of postoperative complications and risk factor analyses
Statistical analysis
Results
Positive culture in gastric juice | Group NGC n = 45 | Group GC n = 21 | p value |
---|---|---|---|
Fungus species | 0 | 21 (100%) | |
Candida albicans | 0 | 15 (71.4%) | < 0.001 |
Candida glabrata | 0 | 8 (38.1%) | < 0.001 |
Candida tropicalis | 0 | 1 (4.8%) | 0.318 |
Bacterial species | 26 (57.8%) | 13 (61.9%) | 0.751 |
Gram-positive species | |||
Streptococcus species | 19 (42.2%) | 2 (9.5%) | 0.008 |
Enterococcus species | 4 (8.9%) | 6 (28.6%) | 0.047 |
Staphylococcus species | 8 (17.8%) | 2 (9.5%) | 0.318 |
Corynebacterium species | 6 (13.3%) | 3 (14.3%) | 0.596 |
Bacillus species | 2 (4.4%) | 0 | 0.462 |
Lactobacillus species | 1 (2.2%) | 0 | 0.682 |
Gram-negative species | |||
Neisseria species | 7 (15.6%) | 1 (4.8%) | 0.203 |
Escherichia coli | 0 | 2 (9.5%) | 0.098 |
Enterobacter species | 0 | 4 (19.0%) | 0.008 |
Klebsiella species | 0 | 1 (4.8%) | 0.318 |
Pseudomonas aeruginosa | 0 | 1 (4.8%) | 0.318 |
Morganella morganii | 0 | 1 (4.8%) | 0.318 |
Raoultella planticola | 1 (2.2%) | 0 | 0.682 |
Microbiological characteristics
Patient characteristics according to the presence of gastric Candida colonization
Variables | Group NGC n = 45 | Group GC n = 21 | p value |
---|---|---|---|
Preoperative variables | |||
Age, years | 69 [23–91] | 69 [49–82] | 0.526 |
Gender, male/female | 31/14 (68.9%) | 10/11 (47.6%) | 0.097 |
BMI (kg/m2) | 20.8 [15.2–31.4] | 21.5 [16.3–27.2] | 0.980 |
Performance status: 0/1 | 39/6 | 17/4 | 0.396 |
Cachexia (yes/no) | 9/36 (20.0%) | 7/14 (33.3%) | 0.239 |
Diabetes mellitus (yes/no) | 12/33 (26.7%) | 5/16 (23.8%) | 0.805 |
Hypertension (yes/no) | 20/25 (44.4%) | 9/12 (42.9%) | 0.904 |
Dyslipidemia (yes/no) | 14/31 (31.1%) | 6/15 (28.6%) | 0.834 |
Smoking: Brinkman index > 400 (yes/no) | 20/25 (44.4%) | 6/15 (28.6%) | 0.219 |
Alcohol consumption > 60 g/day (yes/no) | 8/37 (17.8%) | 2/19 (9.5%) | 0.318 |
History of other malignant disease (yes/no) | 9/36 (20.0%) | 6/15 (28.6%) | 0.318 |
Administration of PPI or H2 receptor blocker (yes/no) | 23/22 (51.1%) | 15/6 (71.4%) | 0.120 |
Therapeutic use of glucocorticoid (yes/no) | 2/43 (4.4%) | 0/21 (0.0%) | 0.462 |
Total parenteral nutrition (yes/no) | 1/44 (2.2%) | 0/21 (0.0%) | 0.682 |
Biliary drainage (yes/no) | 15/30 (33.3%) | 12/9 (57.1%) | 0.067 |
History of broad-spectrum antibiotics (yes/no) | 8/37 (17.8%) | 8/13 (38.1%) | 0.073 |
Chemotherapy (yes/no) | 10/35 (22.2%) | 6/15 (28.6%) | 0.575 |
Chemoradiotherapy (yes/no) | 11/34 (24.4%) | 10/11 (47.6%) | 0.060 |
Primary disease (malignancy/benign) | 34/11 (75.6%) | 19/2 (90.5%) | 0.137 |
Diagnosis | |||
PDAC/IPMN/BDC/HCC/others | 16/7/7/6/9 | 14/1/3/0/3 | 0.112 |
Albumin (g/dl) | 3.7 [3.0–4.6] | 3.7 [2.9–4.9] | 0.326 |
White blood cell counts (/mm2) | 5000 [2580–13,290] | 4880 [2480–7690] | 0.259 |
Hemoglobin (g/dl) | 12.3 [8.4–17.5] | 11.7 [8.7–15.8] | 0.237 |
Platelet counts (× 103 ml) | 197 [110–737] | 200 [68–340] | 0.736 |
C-reactive protein (mg/l) | 0.12 [0.01–4.06] | 0.12 [0.03–3.78] | 0.929 |
NLR | 2.52 [0.89–13.5] | 3.00 [0.90–5.04] | 0.397 |
PNI | 45.4 [33.4–56.0] | 41.5 [36.4–55.9] | 0.100 |
Intraoperative variables | |||
Operation procedure Pancreaticoduodenectomy/other pancreatectomy/hepatectomy/others | 26/5/11/3 | 16/3/2/0 | 0.272 |
Operative duration (min) | 446 [198–972] | 541 [348–880] | 0.012 |
Blood loss (g) | 566 [10–6017] | 716 [151–4386] | 0.256 |
Blood transfusion (yes/no) | 18/27 (40.0%) | 10/11 (47.6%) | 0.560 |
Comparisons of postoperative infectious complications between groups NGC and GC
Postoperative complications | Group NGC n = 45 | Group GC n = 21 | p value | |
---|---|---|---|---|
SSIs (yes/no) | 8/37 (17.8%) | 12/9 (57.1%) | 0.001 | |
Incisional SSIs (yes/no) | 0/45 (0%) | 1/20 (4.8%) | 0.318 | |
Organ or space SSIs (yes/no) | 8/37 (17.8%) | 11/10 (52.4%) | 0.004 | |
Postoperative complications of C-D ≥ IIIa (yes/no) | 10/35 (22.2%) | 11/10 (52.4%) | 0.014 | |
IIIa | Pancreatic fistula | 3 | 2 | 0.513 |
Unknown cause abscess | 3 | 4 | 0.138 | |
Biliary fistula | 1 | 1 | 0.538 | |
Massive ascites | 0 | 1 | 0.318 | |
Hepaticojejunostomy stricture | 1 | 0 | 0.682 | |
IIIb | Anastomotic stenosis of portal vein† | 1 | 1 | 0.538 |
IVa | Respiratory dysfunction | 0 | 1 | 0.318 |
IVb | Respiratory and renal dysfunction | 1 | 1 | 0.538 |
Duration of ICU stay, days | 1 [1–20] | 1 [1–6] | 0.753 | |
Duration of hospital stay after operation, days | 24 [10–74] | 32 [18–68] | 0.024 | |
Readmission, yes/no (%) | 7/38 (15.6%) | 11/10 (52.4%) | 0.002 | |
Cholangitis | 3 | 4 | 0.138 | |
Liver abscess | 0 | 2 | 0.098 | |
Malnutrition | 0 | 2 | 0.098 | |
Others | 4 | 3 | 0.393 |
N | Op | Enterotomy | Gastric juice | SSIs | ||
---|---|---|---|---|---|---|
Infected sites | POD | Microbiological species | ||||
Group NGC | ||||||
1 | Hep | No | Streptococcus spp., CNS | IAA | 7 | Enterobacter asburiae |
2 | Hep | Yes | Negative | BF | 8 | Enterococcus faecalis, Enterococcus fecium, CNS |
3 | DP | No | Negative | PF | 10 | MRSA, CNS |
4 | DP | No | a-, r-Streptococcus | PF | 7 | NA |
5 | SSPPD | Yes | Bacillus species | PF | 11 | Negative |
6 | SSPPD | Yes | Negative | IAA | 7 | Enterococcus faecalis |
7 | Hep | No | a-, r-Streptococcus, Neisseria species | IAA | 14 | Negative |
8 | SSPPD | Yes | Negative | PF | 6 | Negative |
Group GC | ||||||
1 | Hep | No | Ca | IAA | 6 | CNS |
2 | SSPPD | Yes | Ca | IAA | 12 | CNS |
3 | SSPPD | Yes | Ca, Cg | BF | 3 | Cg, Enterobacter spp., Enterococcus faecalis |
4 | SSPPD | Yes | Ca, Cg, Escherichia coli | Ascites | 6 | Cg, Bacillus cereus |
5 | SSPPD | Yes | Ca | Wound | 7 | Enterococcus faecalis, Enterococcus avium |
6 | SSPPD | Yes | Ca, Pseudomonas aeruginosa, Enterobacter spp., Escherichia coli | PF | 6 | NA |
7 | DP | No | Cg, Klebsiella pneumoniae | PF | 11 | MSSA, Enterococcus faecalis, coryneform bacteria |
8 | SSPPD | Yes | Ca, Morganella morganii | Ascites | 6 | Enterococcus faecalis, Pseudomonas aeruginosa |
9 | Hep | Yes | Cg | IAA | 10 | Enterococcus faecalis, Enterobacter aerogenes |
10 | SSPPD | Yes | Cg, coryneform bacteria | IAA | 9 | Cg, Leuconostoc pseudomesenteroides, Citrobacter farmeri, Klebsiella oxytoca, Fusobacterium varium |
11 | DP | No | Ca, Streptococcus spp., Neisseria spp. | PF | 10 | Negative |
12 | SSPPD | Yes | Ca, Enterococcus faecalis, coryneform bacteria | IAA | 14 | Enterococcus faecalis |
Uni- and multivariate analyses for identifying pre- and intraoperative variables associated with SSIs
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
SSIs no n = 46 | SSIs yes n = 20 | p value | Odds ratio | 95% CI | p value | |
Preoperative variables | ||||||
Age (years) | 69 [23–91] | 69 [32–83] | 0.328 | |||
Gender (male/female) | 30/16 (65.2%) | 11/9 (55.0%) | 0.432 | |||
BMI (kg/m2) | 20.7 [15.2–31.4] | 22.0 [18.1–27.3] | 0.276 | |||
Performance status: 0/1 | 40/6 | 16/4 | 0.352 | |||
Cachexia (yes/no) | 10/36 (21.7%) | 6/14 (30.0%) | 0.336 | |||
Diabetes mellitus (yes/no) | 13/33 (28.3%) | 4/16 (20.0%) | 0.481 | |||
Hypertension (yes/no) | 20/26 (43.5%) | 9/11 (45.0%) | 0.909 | |||
Dyslipidemia (yes/no) | 15/31 (32.6%) | 5/15 (25.0%) | 0.536 | |||
Smoking: Brinkman index > 400 (yes/no) | 16/30 (34.8%) | 10/10 (50.0%) | 0.245 | |||
Alcohol consumption > 60 g/day (yes/no) | 8/38 (17.4%) | 2/18 (10.0%) | 0.359 | |||
Past history of malignant disease (yes/no) | 11/35 (23.9%) | 4/16 (20.0%) | 0.498 | |||
Administration of PPI or H2 receptor blocker (yes/no) | 27/19 (58.7%) | 11/9 (55.0%) | 0.780 | |||
Therapeutic use of glucocorticoid (yes/no) | 2/44 (4.3%) | 0/20 (0%) | 0.483 | |||
Total parenteral nutrition (yes/no) | 0/46 (0.0%) | 1/19 (5.00%) | 0.303 | |||
Biliary drainage (yes/no) | 19/27 (41.3%) | 8/12 (40.0%) | 0.921 | |||
History of broad-spectrum antibiotics (yes/no) | 10/36 (21.7%) | 6/14 (30.0%) | 0.336 | |||
Chemotherapy (yes/no) | 13/33 (28.3%) | 3/17 (15.0%) | 0.202 | |||
Chemoradiotherapy (yes/no) | 15/31 (32.6%) | 6/14 (30.0%) | 0.834 | |||
Primary disease (malignancy/benign) | 37/9 (80.4%) | 16/4 (80.0%) | 0.606 | |||
Diagnosis PDAC/IPMN/BDC/HCC/others | 21/6/6/5/8 | 9/2/4/1/4 | 0.889 | |||
Gastric Candida colonization (yes/no) | 9/37 (19.6%) | 12/8 (60.0%) | 0.001 | 6.17 | 1.95–19.5 | 0.002 |
Gastric bacterial colonization | 27/19 (58.7%) | 12/8 (60.0%) | 0.921 | |||
Albumin (g/dl) | 3.7 [3.0–4.6] | 3.9 [2.9–4.9] | 0.713 | |||
White blood cell counts (/mm2) | 4955 [2480–13,290] | 5070 [2670–8170] | 0.873 | |||
Hemoglobin (g/dl) | 12.1 [8.4–17.5] | 11.9 [8.8–15.8] | 0.564 | |||
Platelet counts (× 103 ml) | 197 [96–737] | 212 [68–340] | 0.596 | |||
C-reactive protein (mg/l) | 0.12 [0.01–4.06] | 0.13 [0.01–3.78] | 0.451 | |||
NLR | 2.83 [1.02–13.5] | 2.04 [0.89–5.04] | 0.084 | |||
PNI | 43.2 [36.3–56.0] | 45.6 [33.4–56.0] | 0.337 | |||
Intraoperative variables | ||||||
Operation procedure Pancreaticoduodenectomy/other pancreatectomy Hepatectomy/others | 31/4/8/3 | 11/4/5/0 | 0.318 | |||
Operative duration (min) | 459 [198–972] | 494 [244–880] | 0.831 | |||
Blood loss (g) | 589 [54–6017] | 679 [10–4386] | 0.967 | |||
Blood transfusion (yes/no) | 18/28 (39.1%) | 10/10 (50.0%) | 0.412 |